FRAMEWORK FOR REDUNDANCY IN GENOMIC DATA STORAGE

1. Introduction

Redundancy in genomic data storage refers to maintaining multiple secure copies of genomic information across different storage systems, locations, or infrastructure to prevent data loss, corruption, and service interruption. Genomic data includes DNA sequences, whole-genome sequencing files, genetic test results, and associated clinical information. Such information is highly sensitive because it may reveal inherited diseases, biological relationships, and health risks affecting individuals and their relatives.

An effective redundancy framework combines backup systems, geographical replication, encryption, access controls, integrity verification, and disaster recovery procedures. Its purpose is to ensure that genomic data remains available, accurate, confidential, and recoverable throughout its retention period.

2. Objectives of Genomic Data Redundancy

The principal objectives are:

Data availability: Ensuring authorised researchers and healthcare professionals can access genomic information when required.

Prevention of data loss: Protecting against hardware failure, accidental deletion, cyberattacks, and natural disasters.

Data integrity: Ensuring replicated genomic files remain identical to the original authorised records.

Privacy protection: Preventing unauthorised access to replicated copies.

Regulatory compliance: Supporting applicable data-protection, research-ethics, and medical-record obligations.

Research continuity: Preserving valuable genomic datasets for longitudinal studies and reproducibility.

Because genomic information is difficult or impossible to recreate from the original source after a sample has been destroyed, reliable storage and recovery arrangements are particularly important.

3. Key Elements of the Redundancy Framework

A. Multiple Storage Copies

Organisations should maintain multiple copies of critical genomic datasets. A commonly used approach is the 3-2-1 backup rule: three copies of the data, stored on two different types of media, with at least one copy kept off-site.

For genomic databases, this may involve a primary research server, a secondary backup system, and an encrypted off-site or cloud-based copy. The copies should not all depend on the same physical infrastructure or administrative credentials.

B. Geographical Replication

Copies should be distributed across separate geographical locations to reduce the risk of simultaneous destruction caused by fire, flooding, power failure, or other regional disasters.

Cross-border replication requires additional legal review because genomic information may be subject to restrictions on international transfers, localisation, and access by foreign entities.

C. Data Integrity and Verification

Genomic files must remain scientifically accurate. Organisations should use cryptographic hashes, checksums, version control, and scheduled restoration tests to detect corruption or unauthorised alteration.

For example, a checksum can help establish whether a replicated sequencing file has changed during transfer. However, integrity verification alone cannot prove that the original sequence was scientifically correct.

D. Encryption and Access Controls

Every redundant copy should be protected by encryption during transmission and storage. Access should be restricted according to role, research purpose, and authorisation.

Multi-factor authentication, separate backup credentials, encryption-key management, access logs, and immutable backups can reduce the risk of ransomware and insider misuse.

E. Disaster Recovery and Business Continuity

A written disaster-recovery plan should specify recovery time objectives (RTOs), recovery point objectives (RPOs), responsible personnel, backup frequency, and escalation procedures.

RTO: The maximum targeted time required to restore access.

RPO: The maximum acceptable period of data loss measured in time.

Critical clinical genomic services may require shorter recovery targets than historical research archives. These targets should be based on clinical risk, operational needs, and applicable legal requirements.

F. Privacy, Retention, and Secure Deletion

Redundancy must not become indefinite, uncontrolled duplication. Organisations should maintain an inventory of copies, apply retention schedules, and ensure that authorised deletion reaches backup systems when technically and legally required.

Where genomic data has been pseudonymised, it should still be treated as potentially identifiable. Genetic information can sometimes be linked back to individuals through comparison with other datasets.

4. Legal and Regulatory Framework

A. Digital Personal Data Protection Act, 2023 (India)

The Act provides a framework for processing digital personal data, including applicable obligations concerning security safeguards, subject to its provisions and commencement status. Genomic information that identifies or relates to an identifiable individual may fall within its scope.

Data fiduciaries should assess security safeguards, access governance, incident response, and the handling of replicated records in accordance with applicable requirements. The Act does not prescribe a universal three-copy backup architecture.

B. Information Technology Act, 2000

Section 43A historically addressed compensation for failure to protect sensitive personal data or information by a body corporate, while Section 72A concerns disclosure of information in breach of lawful contract. Section 43A's current applicability must be assessed in light of the DPDP Act's commencement and repeal provisions.

C. Information Technology Rules, 2011

The Information Technology (Reasonable Security Practices and Procedures and Sensitive Personal Data or Information) Rules, 2011 established requirements concerning specified sensitive personal information, including certain medical records and information about physical or mental health. Their present applicability must be checked against subsequent legislative changes and the particular data-processing arrangement.

D. General Data Protection Regulation (GDPR)

Where applicable, the GDPR provides relevant safeguards for genomic data:

Article 5 establishes principles including integrity, confidentiality, and storage limitation.

Article 9 generally prohibits processing special-category data, including genetic data, unless an applicable exception permits it.

Article 32 requires appropriate technical and organisational security measures, including, where appropriate, the ability to restore availability and access to personal data after an incident.

Article 17 addresses erasure rights, subject to exceptions.

The GDPR supports resilient storage but does not require every genomic database to use a particular number of copies.

5. Important Case Laws

A. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) 10 SCC 1

The Supreme Court of India recognised privacy as a fundamental right under Article 21 and the broader constitutional framework. The judgment is important for genomic data storage because genetic information can reveal deeply personal details about health, family relationships, and biological identity.

Application: Redundant copies should be subject to purpose limitation, proportionate access controls, confidentiality safeguards, and appropriate governance. Creating additional copies should not unnecessarily increase privacy risks.

B. K.S. Puttaswamy v. Union of India (Aadhaar), (2019) 1 SCC 1

In its Aadhaar judgment, the Supreme Court examined privacy, proportionality, and the use of identity-related information. Although the case did not specifically determine genomic-storage redundancy standards, its reasoning is relevant to the proportionality of collecting, retaining, and securing sensitive datasets.

Application: Organisations should justify the purposes of retaining genomic copies and implement safeguards proportionate to the sensitivity and potential consequences of unauthorised disclosure.

C. Shreya Singhal v. Union of India (2015) 5 SCC 1

The Supreme Court struck down Section 66A of the Information Technology Act and considered other provisions governing online information and intermediary responsibilities.

Application: The decision provides broader context for India's digital-information legal framework, but it does not establish technical requirements for backup systems, genomic data replication, or disaster recovery.

Important clarification: Indian courts have not established a comprehensive, genomics-specific doctrine requiring a fixed number of redundant storage copies. The cases above supply constitutional and digital-governance principles rather than direct rulings on genomic backup architecture.

6. Implementation and Risk Management

A practical implementation plan should include:

Classifying genomic datasets according to clinical importance and sensitivity.

Establishing encrypted primary, secondary, and geographically separated backup copies.

Separating backup administration from ordinary production-system access.

Testing restoration procedures periodically and documenting the results.

Maintaining audit trails for access, copying, modification, and deletion.

Reviewing cloud-provider contracts, subcontractors, and international data transfers.

Testing disaster recovery and ransomware response through simulated incidents.

Periodically reviewing retention requirements and eliminating unnecessary copies.

An organisation should also evaluate whether replicated datasets include associated metadata, linkage keys, consent records, and research annotations, since losing these materials may make otherwise intact genomic files unusable.

7. Conclusion

Redundancy in genomic data storage is a critical component of data protection, scientific reliability, and healthcare continuity. An effective framework combines geographically distributed backups, encryption, integrity verification, disaster recovery, controlled access, and legally compliant retention practices. Indian constitutional privacy jurisprudence and applicable data-protection laws provide important governance principles, while technical standards and risk assessments determine the appropriate storage architecture. The ultimate objective is to ensure that genomic information remains recoverable and accurate without creating unnecessary privacy, security, or compliance risks.